OxfordOxford Mon - Fri 09:00-17:00 +44(0)1865-600222
LibPubMedia1@gmail.com
OxfordOxford Mon - Fri 09:00-17:00 +44(0)1865-600222
LibPubMedia1@gmail.com
J Venom Res
Open-access
Aptamers
Open-access
Aptamers 2019
03-04 April 2019, Oxford
Submit a manuscript

Category

Aptamers 2018 News
Aptamer Solutions Ltd: Continued success and growth has enabled Aptamer Group to restructure its Scientific Operations team. Increasing interest in the development of aptamers against small molecule targets has led to the formation of a dedicated scientific team. This is in addition to the existing team focused on aptamer generation against larger targets (proteins, viruses,...
Read More
Pure Biologics is a biopharmaceutical company. We are conducting in-house research projects for the development of new biopharmaceutical drugs, diagnostics tests and therapeutical medical devices. Our company has a unique technological know-how with proprietary platforms for selection of antibody fragments and chemically modified aptamers. We are leveraging these technologies to employ biological binding entities for drug...
Read More
Centauri Therapeutics Ltd is a UK-based biotechnology company focused on the discovery and development of novel molecules targeting life threatening diseases. The company has established a core R&D facility at Discovery Park in Sandwich, Kent, with an experienced team of industry scientists focused on discovery, optimisation and development of novel Alphamers targeting acute hospital acquired infections....
Read More
SomaLogic is transforming healthcare by applying our proprietary protein-measurement technology to enable the precise monitoring of each individual’s health and wellness status in real time. We work with many different partners across research, health management, pharmaceutical development, and other health-related fields to build applications on our “SOMAscan Platform,” a single cost-effective and reliable testing platform that...
Read More
RIBOMIC Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies called the RiboART System. RIBOMIC has been promoting the pharmaceutical discovery program in collaboration with Otsuka Pharmaceutical Co., Ltd., Taisho Pharmaceutical Co., Ltd., The University of Tokyo, and some...
Read More
Membership is currently free and is open to researchers from academia and industry with interest in the field of aptamers. Please complete the registration form to apply for membership. Membership Categories Industry Academic – Lecturer/Professor/Group Leader Academic – Post-doctoral Researcher Academic – Student Become an INSOAP member to access: Job listings in the field of aptamers Occasional...
Read More
Aptamers – The official journal of the International Society on Aptamers – will consider and publish peer-reviewed studies on all aspects of aptamer research. The journal is now accepting manuscripts.  Publish Free: There is no Article Processing Fee until 31 July 2018, as long as the submitted manuscripts are prepared within the recommended size limits and according to...
Read More

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Our Cases